SIADH in Systemic JIA Resolving After Treatment With an IL-6 Inhibitor
- PMID: 29242269
- DOI: 10.1542/peds.2016-4174
SIADH in Systemic JIA Resolving After Treatment With an IL-6 Inhibitor
Abstract
Interleukin-6 (IL-6) is implicated in the pathogenesis of both systemic juvenile idiopathic arthritis (SJIA) and syndrome of inappropriate secretion of antidiuretic hormone (SIADH), but the 2 have not been previously described as occurring together. We report a case of a 6-year-old girl with symptoms of arthralgia, daily fevers, evanescent rash, lymphadenopathy, and laboratory evaluation showing elevated inflammatory markers, consistent with SJIA. At presentation, the patient had hyponatremia with a sodium level of 128 mEq/L. She had low serum osmolality with elevated urine osmolality, consistent with SIADH. Hyponatremia improved temporarily during times of fluid restriction as expected in SIADH, but did not resolve until SJIA was treated successfully with tocilizumab, an IL-6 receptor antibody that inhibits IL-6 activity. The positive response to treatment with tocilizumab supports the role of IL-6 in the pathogenesis of both SJIA and SIADH. Patients with SJIA should be monitored for SIADH to avoid complications of untreated hyponatremia.
Copyright © 2018 by the American Academy of Pediatrics.
Conflict of interest statement
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
Similar articles
-
Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry.Arthritis Res Ther. 2017 Nov 22;19(1):256. doi: 10.1186/s13075-017-1462-2. Arthritis Res Ther. 2017. PMID: 29166924 Free PMC article.
-
Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations.Expert Rev Clin Immunol. 2015 May;11(5):575-88. doi: 10.1586/1744666X.2015.1032257. Epub 2015 Apr 4. Expert Rev Clin Immunol. 2015. PMID: 25843554 Review.
-
Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.J Rheumatol. 2014 Apr;41(4):759-67. doi: 10.3899/jrheum.130690. Epub 2014 Mar 15. J Rheumatol. 2014. PMID: 24634205 Clinical Trial.
-
Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review.BMC Nephrol. 2017 May 12;18(1):159. doi: 10.1186/s12882-017-0573-y. BMC Nephrol. 2017. PMID: 28499374 Free PMC article. Review.
-
Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis.Clin Rev Allergy Immunol. 2005 Jun;28(3):231-8. doi: 10.1385/CRIAI:28:3:231. Clin Rev Allergy Immunol. 2005. PMID: 16129907 Review.
Cited by
-
Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls.Eur J Endocrinol. 2021 Mar;184(3):409-418. doi: 10.1530/EJE-20-1374. Eur J Endocrinol. 2021. PMID: 33449918 Free PMC article.
-
Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective.Biomed Pharmacother. 2021 Nov;143:112193. doi: 10.1016/j.biopha.2021.112193. Epub 2021 Sep 15. Biomed Pharmacother. 2021. PMID: 34543987 Free PMC article. Review.
-
COVID-19 presented with syndrome of inappropriate ADH secretion(SIADH): A case report from Bangladesh.Respir Med Case Rep. 2020;31:101290. doi: 10.1016/j.rmcr.2020.101290. Epub 2020 Nov 12. Respir Med Case Rep. 2020. PMID: 33204610 Free PMC article.
-
What is the aetiology of dysnatraemia in COVID-19 and how is this related to outcomes in patients admitted during earlier and later COVID-19 waves? A multicentre, retrospective observational study in 11 Dutch hospitals.BMJ Open. 2023 Nov 14;13(11):e075232. doi: 10.1136/bmjopen-2023-075232. BMJ Open. 2023. PMID: 37963704 Free PMC article.
-
Disorders of sodium balance in COVID-19 patients: two Tunisian patients report.Pan Afr Med J. 2021 Jul 14;39:199. doi: 10.11604/pamj.2021.39.199.27626. eCollection 2021. Pan Afr Med J. 2021. PMID: 34603580 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical